Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
153.49
+3.73 (2.49%)
At close: Nov 4, 2024, 4:00 PM
150.00
-3.49 (-2.27%)
After-hours: Nov 4, 2024, 5:24 PM EST
Illumina Revenue
Illumina had revenue of $1.11B in the quarter ending June 30, 2024, a decrease of -5.44%. This brings the company's revenue in the last twelve months to $4.43B, down -0.72% year-over-year. In the year 2023, Illumina had annual revenue of $4.50B, down -1.75%.
Revenue (ttm)
$4.43B
Revenue Growth
-0.72%
P/S Ratio
5.36
Revenue / Employee
$331,512
Employees
13,360
Market Cap
24.45B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
| Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
| Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
| Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
| Dec 29, 2019 | 3.54B | 210.00M | 6.30% |
| Dec 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jan 1, 2017 | Pro | Pro | Pro |
| Jan 3, 2016 | Pro | Pro | Pro |
| Dec 28, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cardinal Health | 224.45B |
| Koninklijke Philips | 20.12B |
| Biogen | 9.61B |
| Zimmer Biomet Holdings | 7.60B |
| STERIS | 5.23B |
| DexCom | 3.95B |
| BioNTech SE | 3.39B |
| BeiGene | 3.10B |
ILMN News
- 1 hour ago - Illumina Reports Financial Results for Third Quarter of Fiscal Year 2024 - PRNewsWire
- 4 days ago - Illumina to preview newest innovations in NGS and multiomic technologies at the American Society of Human Genetics Annual Meeting - PRNewsWire
- 26 days ago - Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers - PRNewsWire
- 26 days ago - Illumina launches compact, low-cost gene sequencing devices - Reuters
- 4 weeks ago - Illumina to Announce Third Quarter 2024 Financial Results on Monday, November 4, 2024 - PRNewsWire
- 4 weeks ago - Revisiting Illumina - Seeking Alpha
- 4 weeks ago - Charles Dadswell to step down as General Counsel, Illumina initiates search for successor - PRNewsWire
- 4 weeks ago - Illumina Inc (ILMN) Trading 5.9% Higher on Oct 2 - GuruFocus